Clinical TrialID 2428

Topical Estriol for Vaginal Health

NCT00908570

Vaginal Health

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
2428
Evidence Id
2428
Core Evidence Id
2428
Source Clinical Trial Id
2405
Herb2 Clinical Trial Id
HBCT002405
Nct Id
NCT00908570
Title
Topical Estriol for Vaginal Health
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Vaginal Health
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: PREVENTION
Intervention
DRUG: estriol|DRUG: Placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Prevention
Gender
Female
Age
Adult
Enrollment
104
Outcome Measure
Change in thickness of the vaginal epithelium, Pre and post treatment luteal and follicular phases
Sponsor Collaborator
Gynuity Health Projects|University of Illinois at Chicago|University of California, Los Angeles|Tulane University School of Medicine|Magee-Women's Research Institute|Oregon Health and Science University
Funded By
OTHER
Location
Harbor-UCLA Medical Center, Los Angeles, California, 90502, United States|University of Illinois at Chicago, Chicago, Illinois, 60612, United States
Other Id
5.1
Start Date
2009-06
Primary Completion Date
2011-03
Completion Date
2011-03
First Posted
2009-05-27
Results First Posted
Last Update Posted
2011-03-04
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00908570
Title Cn
Title En
Topical Estriol for Vaginal Health
Bilingual Status
semi_complete